What Influences Advocates of Providing "More, Not Less, Truthful...

Courtesy Health Care Renewal  Mon, 08/04/2008 - 14:35

Last week's New England Journal of Medicine included a letter [Troy DE, Gottlieb S.

Pharmaceutical promotion and first amendment rights. N Engl J Med 2008; 359: 536. ] supporting pharmaceutical companies' rights to promote their products for uses not approved by the US Food and Drug Administration (FDA).

The letter applauded "the robust, sound constitutional protection the U.S. Supreme Court affords truthful, nonmisleading commercial communication such as that embodied in reprints of scientific articles discussing off-label uses."...


 

More related items

Organ donation after cardiac death
(University of Pennsylvania School of Medicine) The Aug. 14 issue of the New England Journal of Medicine explores the issue of organ donation after...

Attacking "Side Effects" with Logical Fallacies, Version 2
Side Effects by Alison Bass continues to generate controversy. As described by a reviewer in the New England Journal of Medicine,(1) the bookused the...

Journal Editors Take Aim at Supreme Court for Gun-Control Ruling
BOSTON -- The landmark Supreme Court decision that struck down the District of Columbia's ban on handguns "has launched the country on a risky...

Disclosure of organ transplant risks: A question of when, not if
(University of Pennsylvania School of Medicine) University of Pennsylvania School of Medicine physicians and bioethicists are calling for a new, more...

Lovely by Sarah Jessica Parker Perfume for Women
New in factory retail box .

A Healthy Horse the Natural Way: A Horse Owner's Guide to Using...

Cliques, Phonies, & Other Baloney
Written for every child who has ever felt shut out or trapped by a clique, this book blends humor with practical advice as it explains how to form...


 

Post new comment

The content of this field is kept private and will not be shown publicly.
health-fitness.marc8.com